NCT06015776View on ClinicalTrials.gov

Purinergic Signaling and the Postmenopausal Heart

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Diastolic Heart FailureHeart Failure With Preserved Ejection Fraction
Interventions
OTHER

Gender

Differences between men and women will be observed

Trial Locations (1)

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER